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for influenza vaccination, ILI symptoms, time off work/education, and HCRU. 
Transmission of ILI from children to adults was estimated. Descriptive statistics 
were used. Results: Across 938 participants/households there were 1895 adults 
mean age 40.6 years, 52.7% females; 1695 children mean age 8.7 years, 46.8% females. 
91/306 adult ILI incidences were related to a child ILI (29.7%, 95%CI:26.5%-33.0%). 69 
of these (75.8%, 95%CI:60.3%-91.3%) had symptom duration> 3 days, 31/86 employed 
(36.0%; 95%CI:28.5%-43.6%) reported taking time off work with 22/31 (71.0%; 
95%CI:46.2%-95.8%) taking ≥ 2 days off. 13/91 (14.3%; 95%CI:11.5%-17.1%) had general 
practice (GP) visits, 5/91 (5.5%; 95%CI:4.5%-6.5%) had GP telephone consultations, 
6/91 (6.6%; 95%CI:5.3%-7.8%) received prescriptions, 76/91 (83.5%; 95%CI:66.5-100.6%) 
used over the counter (OTC) medications because of their ILI. 67 adults reported time 
off because of child ILIs (310 incidences); 30/67 (44.8%; 95%CI:34.2%-55.4%) taking 
≥ 2 days. This represents 67 adults/152 working adults (44.1%; 95%CI:37.2%-51.0%) 
in the child ILI households. 180/310 (58.1%; 95%CI:51.7%-64.5%) of total child ILIs 
had time off education, 81/180 (45.0%; 95%CI:38.5%-51.5%%) taking ≥ 3 days. 59/310 
(19.0%; 95%CI:17.0%-21.1%) had GP visits, 22/310 (7.1%; 95%CI:6.4%-7.8%) had GP 
telephone consultations, 48/310 (15.5%; 95%CI:13.8%-17.2%) received prescriptions, 
234/310 (75.5%; 95%CI:67.1-83.8%) used OTC medications. ConClusions: Based 
on survey, approximately 1/3 of adult ILIs were related to prior household child 
ILI. ILI in a household often required absence from work and ILI in children often 
resulted in time off education. GP visits were the most frequent burden to the 
National Health Service.
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objeCtives: Patients colonized with multidrug-resistant organisms, especially 
Methicillin resistant Staphylococcus aureus (MRSA), impose a risk on other 
patients and on health care professionals. In addition, they will suffer from sub-
stantial health problems when getting an infection. This contribution examines 
the incentives of German rehabilitation centers to implement screening strategies 
to stem nosocomial infections and the spread of MRSA. Methods: Relying on a 
decision tree analysis, the expected health care cost per capita is calculated for 
three strategies: (i) general screening, (ii) risk-based screening, both on admission, 
and (iii) no screening at all. Parameters are taken from the published literature. 
To handle uncertainty, multivariate sensitivity analyses are performed. Results: 
From the perspective of a rehabilitation center, the third strategy yields the lowest 
expected cost while the first one causes the highest cost. This ordering is robust with 
respect to sensitivity analysis. Thus, cost savings due to a lower number of MRSA 
infections are not sufficient to offset the cost of the test and further prevention 
measures applied to individuals with a positive result. ConClusions: In Germany, 
rehabilitation centers are reimbursed by daily rates. In particular, they receive no 
extra fees for prevention measures. As our analysis demonstrates, this implies the 
incentive to implement MRSA screening to be too weak. Hence, MRSA prevention 
measures that would be beneficial to society will not be undertaken. However, our 
results can be used to indicate changes in the remuneration system that would 
provide rehabilitation centers with an appropriate incentive for MRSA prevention. 
Moreover, hygiene regulations enacted very recently (MedHygVO), in the light of 
our analysis, can be interpreted in a similar manner due to the requirement of a 
stricter hygiene regimen.
PIN118
estImatINg the DIreCt meDICal Cost, leNgth of stay aND ImPaCt of 
reImbursemeNt ChaNge oN health Care assoCIateD INfeCtIoNs
Singh R.R., Lawson K.A.
The University of Texas at Austin, Austin, TX, USA
objeCtives: In 2008, the Centers for Medicare and Medicaid Services discontin-
ued reimbursement for health care associated infections (HAIs) not reported to be 
present-on-admission (POA). The study objectives were to examine: (1) the impact 
of this reimbursement change on hospital-level HAI rates; and (2) the differences 
in total direct medical costs and length of stay (LOS) between patients with HAI 
(cases) and without HAI (controls). Methods: We conducted a retrospective, 
interrupted time series analysis using the Nationwide Inpatient Sample obtained 
from the Health care Cost and Utilization Project database for years 2006 to 2010. 
The primary outcome was diagnosis of HAI, identified based on ICD-9-CM codes 
for sepsis, pneumonia, surgical site infections, catheter-associated urinary tract 
infections or blood stream infections from a pool of “at-risk” patients defined as ≥ 
18 years of age, without a diagnosis of cancer, HIV/AIDS or immunocompromised 
condition. Patients with an LOS ≤ 2 days were excluded to avoid inclusion of patients 
with pre-existing infections. Differences in total direct medical costs and LOS of 
propensity score-matched cases and controls were assessed using Wilcoxon signed-
rank tests. Results: The HAI rate was higher in the “at-risk” population (12.95 vs. 
2.83 per 100 admissions) than in the total inpatient population, ≥ 18 years of age. 
Discontinuation of reimbursement for HAI was associated with a 0.37 point (-0.375, 
p = 0.0064) decrease in HAI rate per 100 admissions for “at-risk” patients. Compared 
to controls, cases had significantly higher mean annual total direct medical costs 
($15,313 ± 17,470 vs. $21,561 ± 31,718, p< 0.0001) and a higher mean LOS (7.1 ± 6.5 
vs. 10.2 ± 11.3 days, p< 0.0001). ConClusions: Total direct medical costs and LOS 
are higher for patients with HAI compared to those without HAI. Policy changes in 
the reimbursement of HAI cases made in 2008 showed a reduction in the rate of 
HAIs in the “at-risk” population.
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varicella cases for 75% and 65% VE-D1 was respectively 73.9%/71.3% by year 30 and 
65.0%/61.6% by year 80. When coverage was 75%/60%, the reduction in number of 
varicella cases was 60.2%/58.1% by year 30 and 55.0%/52.5% by year 80 for VE-D1 of 
75% and 65%, respectively. ConClusions: The coverage of varicella vaccination is 
an important factor affecting the number of varicella cases when long term interval 
between two doses is considered. This is a more influential factor on predicted cases 
than the first dose efficacy.
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objeCtives: To examine herpes zoster-related health care resource utilization in 
hematologic (HM) or solid tumor malignancy (STM) patients seeking care at pri-
mary-care practices in 5 European countries. Methods: Longitudinal primary-
care EMR databases (Cegedim Strategic Data) in France, Italy, Germany, Spain, and 
United Kingdom (UK) were analyzed retrospectively (2007-2012). Patients with HM 
or STM diagnoses were followed for a subsequent first herpes zoster (HZ) diagno-
sis (index event). HZ patients were matched with non-HZ (HM and STM) patients 
using propensity scores based on demographics and relevant clinical characteris-
tics. Patients were observed for 6 months pre-index (baseline) and 6 months post-
index. Demographics, comorbidities, pharmacotherapy, and health care resource 
utilization (office visits, specialty referrals, laboratory tests, and prescriptions) were 
reported with statistical significance set at p≤ 0.05. Results: HZ patients meeting 
selection criteria across all 5 countries included 907 HM and 4317 STM. Mean ages 
ranged 64.8±15.5 (Italy-HM) to 71.8±11.5 (France-STM); female gender varied for HM 
from 49% (UK) to 58% (Germany), and STM 56% (UK) to 63% (France). Case and control 
populations were well balanced at baseline. Office visits per patient were signifi-
cantly higher post-index for HZ cohorts across all countries and malignancy types 
(except Spain HM), ranging from 0.5 more visits (Spain-STM, p= 0.009,) to 2.8 more 
(UK-HM, p< 0.001). Significantly more HZ patients had post-index specialty referrals 
(France-STM, 2.6% more, p= 0.05; Germany-STM, 4.8% more, p= 0.012), and signifi-
cantly more HZ patients received prescriptions post-index in all cohorts across all 
countries, varying from 19.2% more patients (Spain-STM, p< 0.001,) to 47.3% (UK-HM, 
p< 0.001). Significantly more HZ patients received laboratory testing, ranging from 
3.2% more patients (Italy-STM, p= 0.006,) to 11.4% (UK-HM, p= 0.003). ConClusions: 
Significantly higher health care resource use was incurred by HZ-afflicted HM and 
STM patients within 6 months of HZ diagnosis for office visits, specialty referrals, 
laboratory testing, and outpatient prescribing compared with matched controls 
across 5 European countries.
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objeCtives: Information on the pattern of health services use by HIV patients is 
required to effectively plan services, particularly in light of increasing non-infec-
tious chronic diseases in this population. This study examined the use of inpatient, 
outpatient, and emergency department (ED) services by HIV positive patients who 
attended Cork University Hospital (CUH) for HIV care in 2012. Methods: All pub-
lic HIV patients who attended CUH for inpatient or outpatient care in 2012 were 
identified using an existing clinical database. Data on outpatient appointments 
by speciality (excluding dialysis), ED visits and inpatient episodes were extracted 
from the hospital information system. Patients with no attendance between Jul-
Dec were censored at the month of last visit. Results: Data were extracted on 
328 patients (3642 patient-months), 1434 outpatient visits (1180 Infectious Disease 
(ID), 254 other), 100 ED visits (58 patients) and 74 inpatient episodes (51 patients). 
Patients had a median of 3 ID outpatient visits (range 0-12), 26% of patients also 
attended other outpatient specialties (median 2, range 1-22). On multivariate 
analysis being more recently diagnosed, and being on ART but not suppressed, or 
starting/stopping ART in 2012 were associated with increased outpatient ID visits, 
while age > 50 years was associated with fewer outpatient ID visits. Those diag-
nosed 2003-2007 and 2008-2011 had significantly more outpatient non-ID visits 
while late diagnosis was associated with fewer non-ID visits. Use of ED services 
was positively associated with unknown risk factor and being diagnosed in 2012. 
Use of inpatient services was positively associated with diagnosis in 2012 and 
negatively associated with a minimum CD4 count ≥ 350 cells/μ l. ConClusions: 
These data provide baseline information on the utilisation rates of ID and other 
specialities by HIV positive patients. Such data are useful for identifying factors 
which could be targeted for quality improvement interventions as well as for 
estimating future service requirements.
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objeCtives: To evaluate the impact of child ILI on working adults’ health, pro-
ductivity and health care resource use (HCRU); and to evaluate ILI’s impact on the 
children. Methods: Participants ≥ 18 years, full or part time working and with 
minimum one child ≤ 17 years residing in household were recruited nationally 
(UK) for this online survey between October 2012 and May 2013. Demographics, 
employment status, morbidities and influenza vaccination history were collected 
for all household members. During follow-up, households were surveyed fortnightly 
